Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 15.14% | 11.21% | -84.39% | -275.43% | -219.24% |
| Total Depreciation and Amortization | -25.15% | -4.57% | 27.25% | 68.64% | 186.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.47% | 66.89% | 202.48% | -65.14% | -74.45% |
| Change in Net Operating Assets | 72.42% | 29.76% | 12.19% | -159.13% | -145.78% |
| Cash from Operations | 42.69% | 26.60% | -24.58% | -177.21% | -146.82% |
| Capital Expenditure | 66.16% | 80.29% | 83.74% | 71.92% | 68.28% |
| Sale of Property, Plant, and Equipment | -- | 4,268.18% | 8,390.91% | 4,541.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.30% | 74.12% | 118.92% | 111.92% | 116.54% |
| Cash from Investing | 203.33% | 118.24% | 115.65% | 109.59% | 113.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 107.94% | 98.52% | 98.85% | 100.00% |
| Issuance of Common Stock | -41.38% | -37.31% | -45.43% | -40.74% | -78.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.51% | -- | -- | -487.00% | 76.02% |
| Cash from Financing | -41.34% | -38.48% | -46.94% | -43.86% | -78.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.46% | 59.34% | 55.98% | -9,820.13% | -220.24% |